BioCentury
ARTICLE | Financial News

Foamix sets IPO range

September 4, 2014 12:49 AM UTC

Israeli dermatology play Foamix Pharmaceuticals Ltd. (Ness Ziona, Israel) amended its IPO on NASDAQ and now plans to sell 5.9 million shares at $10-$12. At the $11 midpoint, the company would raise $65 million and be valued at $218.8 million. Foamix filed to raise up to $74.8 million last month. Barclays; Cowen; Oppenheimer; and Maxim Group are underwriters. ...